HelixoMetry, Inc. is a privately held, Silicon Valley based Intellectual Capital Portfolio
* FRACTOGENE PATENT PENDING *
Founder of Helixometry
tel: (408) 891-7187
Aug 1, 2002
FractoGene Patent Pending. Initial offerings outlined, first in a closely held manner.
FractoGene of HelixoMetry is marketed in 7 overlapping Business Models
"Seven Sisters":
(1) Translation Memory Company, Partnership / M/A
(2) "Big Pharma" Pharmaceutical Company, M/A, Director of "in house" Data-Base and Drug Discovery IT.
Advantage: Capital- and wet R&D-readiness by big pharma, biggest cash leverage for holding key FractoGene patent. Overlaps with 4,5.
SCHERING-PLOUGH (Talks started through DNAX in May 2002)
PFIZER
MERCK
JOHNSON & JOHNSON
BRISTOL-MYERS SQUIBB
AMERICAN HOME PRODUCTS
WARNERLAMBERT
PHARMACIA & UPJOHN
BECTON DICKINSON
BAUSCH & LOMB
FOREST LABORATORIES
BLOCK DRUG CO
CARTERWALLACE
NBTY INC
ELI LILLY
ALPHARMA
BAYER
NOVARTIS
ASTRAZENECA
GLAXOSMITHKLINE
MAXIM
ROCHE
TANABE
WYETH
ICN
AVENTIS
TAP
BARR LABORATORIES
MYLAN PHARMACEUTICALS
PHARMACIA
BAXTER INTERNATIONAL
HOECHST
DOW CHEMICAL
3M
ABOTT
MONTEDISON
AB ASTRA
AMGEN
BECKMAN COULTER
ALLERGAN
GENENTECH
CHIRON
WATSON PHARMACEUTICALS
(3) "Big IT" Information Technology Company, Acquisition
(4) Bioinformatics Company Cooperation / Partnership
(5) Genomics Data-Base Company, M/A / Partnership
(6) University R&D Center, M/A / Professorship / Directorship
(7) Regional Center Uniqueness Cooperation / Directorship